Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)-
Pterisolic acid F
CAS: 1401419-90-6
Molecular Formula: C20H30O6
Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)- - Names and Identifiers
| Name | Pterisolic acid F |
| Synonyms | Pterisolic acid F Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)- (4alpha,16alpha)-9,16,17-Trihydroxy-15-oxokauran-18-oic acid |
| CAS | 1401419-90-6 |
Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)- - Physico-chemical Properties
| Molecular Formula | C20H30O6 |
| Molar Mass | 366.45 |
| Density | 1.36±0.1 g/cm3(Predicted) |
| Boling Point | 583.6±50.0 °C(Predicted) |
| Appearance | Powder |
| pKa | 4.52±0.70(Predicted) |
| Storage Condition | 2-8℃ |
| MDL | MFCD28009429 |
Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)- - Introduction
Pterisolic acid F is a natural organic compound, often extracted from the genus Dryopteris. Its chemical formula is C17H12O7 and its molecular weight is 332.27.
The following are the properties and uses of Pterisolic acid F:
-Properties: Pterisolic acid F is a yellow crystalline powder with a benzofuran skeleton structure. It is soluble in solvents but less soluble in water.
-Uses: Pterisolic acid F has potential anti-inflammatory, anti-tumor and antibacterial activities in the pharmaceutical field. Studies have also shown that it may have a protective effect on the cardiovascular system and have antioxidant properties.
The preparation method of Pterisolic acid F is relatively complicated, and it is often synthesized by extracting the compounds in the genus Dryopteris, carrying out multi-step reaction and separation and purification.
With regard to the safety information of Pterisolic acid F, there are limited studies on its toxicity and side effects. Therefore, when using and handling Pterisolic acid F, the guidelines for safe operation of the relevant chemicals should be followed. At the same time, the necessary toxicological and safety assessments are recommended if further research or application to drug development is required. In all cases, correct laboratory safety practices should be followed and adequate precautions maintained.
The following are the properties and uses of Pterisolic acid F:
-Properties: Pterisolic acid F is a yellow crystalline powder with a benzofuran skeleton structure. It is soluble in solvents but less soluble in water.
-Uses: Pterisolic acid F has potential anti-inflammatory, anti-tumor and antibacterial activities in the pharmaceutical field. Studies have also shown that it may have a protective effect on the cardiovascular system and have antioxidant properties.
The preparation method of Pterisolic acid F is relatively complicated, and it is often synthesized by extracting the compounds in the genus Dryopteris, carrying out multi-step reaction and separation and purification.
With regard to the safety information of Pterisolic acid F, there are limited studies on its toxicity and side effects. Therefore, when using and handling Pterisolic acid F, the guidelines for safe operation of the relevant chemicals should be followed. At the same time, the necessary toxicological and safety assessments are recommended if further research or application to drug development is required. In all cases, correct laboratory safety practices should be followed and adequate precautions maintained.
Last Update：2024-04-09 21:54:55
Supplier List
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: +16314854226
Email: info@bocsci.com
Mobile: +16314854226
Linkedin: https://www.linkedin.com/company/boc-sciences
Product List: View Catalog
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotation
CAS: 1401419-90-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
CAS: 1401419-90-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: +16314854226
Email: info@bocsci.com
Mobile: +16314854226
Linkedin: https://www.linkedin.com/company/boc-sciences
Product List: View Catalog
Spot supply
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotationCAS: 1401419-90-6
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Product Name: Pterisolic acid F Visit Supplier Webpage Request for quotation
CAS: 1401419-90-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
CAS: 1401419-90-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
View History
Kauran-18-oic acid, 9,16,17-trihydroxy-15-oxo-, (4α,16α)-
Bis[methylbis[[2-(2-henicosenylcarbonyloxy)ethyl]thio]stannyl] sulfide
1-Acetyl-3,6-bis(tert-butylthio)-1,2,3,6-tetrahydropyridin-2-ol acetate
50658-30-5
107647-20-1
ER 155055-90 Perampanel
1357147-38-6
tert-Butyl-4-acetylpiperidin-1-carboxylat
N'-(3-chlorophenyl)-N-[2-[2-(4-methoxyphenyl)-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazol-5-yl]ethyl]oxamide
2-(morpholin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
Bis[methylbis[[2-(2-henicosenylcarbonyloxy)ethyl]thio]stannyl] sulfide
1-Acetyl-3,6-bis(tert-butylthio)-1,2,3,6-tetrahydropyridin-2-ol acetate
50658-30-5
107647-20-1
ER 155055-90 Perampanel
1357147-38-6
tert-Butyl-4-acetylpiperidin-1-carboxylat
N'-(3-chlorophenyl)-N-[2-[2-(4-methoxyphenyl)-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazol-5-yl]ethyl]oxamide
2-(morpholin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine